Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 72 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
711 14.7 months metastatic breast cancer 4 Chemotherapy
M.D. Anderson Cancer Center United States 9/2005
Treatment Details: Patients: This Phase II study involved 63 women with advanced metastatic breast cancer. The mean age was 48.2 years. Forty-five women were from Indian-Eastern descent, while fourteen were
 
712 14.7 months metastatic breast cancer 4 Chemotherapy
M.D. Anderson Cancer Center United States 9/2005
Treatment Details: Patients: This Phase II study involved 63 women with metastatic breast cancer. Forty-eight patients had received prior chemotherapy; 39 patients had received no prior treatment for metastat
 
713 14.7 months Hormone-refractory prostate cancer 3 Chemotherapy
National Cancer Institute, National Institutes of Health United States 7/2004
Treatment Details: Patients: This Phase II trial involved a total of 75 patients with hormone refractory (androgen-independent) prostate cancer. Patients were divided into two groups: Group 1 comprised of 25
 
714 14.7 months Metastatic colorectal cancer 5 Chemotherapy
University of Oxford United Kingdom 2/2003
Treatment Details: Patients: 290 patients with colorectal cancer with metastases confined to the liver were involved in this study. Patients were divided into two groups: an intrahepatic treatment group comp
 
715 14.7 months Metastatic colorectal cancer 5 Chemotherapy
University of Oxford United Kingdom 2/2003
Treatment Details: Patients: 290 patients with colorectal cancer with metastases confined to the liver were involved in this study. Patients were divided into two groups: an intrahepatic treatment group comp
 
716 14.5 months Newly diagnosed GBM 5 Chemotherapy
Radiation
University of Vienna Austria 2/2003
Treatment Details: Patients: This study involved 55 patients with newly diagnosed glioblastoma multiforme. Treatment: The treatment consisted of two chemotherapy drugs - dacarbazine (DTIC-Dome) and fotemust
 
717 14.5 months Advanced or metastatic breast cancer 5 Chemotherapy
Baylor-Sammons Cancer Center United States 6/2002
Treatment Details: Patients: This Phase III study involved 511 women with metastatic breast cancer or breast cancer that was unresectable and locally advanced. Patients were divided into two groups: Group A c
 
718 14.5 months metastatic breast cancer 4 Chemotherapy
Indiana University United States 2/2005
Treatment Details: Patients: This Phase III study involved 462 women with metastatic breast cancer. The patients were randomly divided into two groups. In Group A, there were 230 patients mean age 52). Tr
 
719 14.5 months metastatic melanoma 3 Chemotherapy
Mayo Clinic United States 6/2005
Treatment Details: Patients: This Phase II study involved 27 patients with metastatic malignant melanoma. Eighteen patients were men, and nine were women. The median age was 56. Metastatic sites included ly
 
720 14.5 months Locally advanced NSCLC 5 Chemotherapy
Radiation
University Hospital France 9/2005
Treatment Details: Patients: This Phase III study involved 201 patients with advanced non-small-cell lung cancer who were randomly assigned into two groups. Group A had 91 men and 10 women with a median age o
 
Page 72 of 187  | Previous Page  | Next Page